Elefteriades John A, Ziganshin Bulat A
Aortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Connecticut.
Aortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Connecticut; Department of Surgical Diseases #2, Kazan State Medical University, Kazan, Russia.
Semin Thorac Cardiovasc Surg. 2016;28(4):776-782. doi: 10.1053/j.semtcvs.2016.10.006. Epub 2016 Oct 14.
Thoracic aortic aneurysms (TAA) pose a serious detection challenge owing to their clinically silent nature. Only a small fraction of TAAs cause symptoms in patients. However, the mortality burden of this disease in the population is significant, given the high lethality of such complications as aortic rupture and dissection. Widespread screening for TAA has not been shown to be cost-effective. Therefore, currently most patients with a TAA are identified incidentally during an imaging study conducted for other reasons. Once a TAA diagnosis is established, prophylactic surgical treatment can safely be performed for aneurysms of the ascending aorta, aortic arch, and descending or thoracoabdominal aorta, thus preventing aneurysm-related death. To facilitate early detection of TAA, recent studies have identified several "associates" of TAA that may be useful in making a timely diagnosis. These "associates" include intracranial aneurysm, aortic arch anomalies, abdominal aortic aneurysm, simple renal cysts, bicuspid aortic valve, temporal arteritis, a positive family history of aneurysm disease, and a positive thumb-palm sign, among others. Although for many of these "associates" the underlying mechanism that would explain the association remains to be elucidated, the clinical correlation is strong enough to suggest screening patients with these findings for TAA. This article introduces the "Guilt by Association" paradigm for detection of silent thoracic aortic disease based on detection of clinical markers associated with this condition.
由于胸主动脉瘤(TAA)临床上无症状的特性,其检测面临严峻挑战。只有一小部分胸主动脉瘤会使患者出现症状。然而,鉴于主动脉破裂和夹层等并发症的高致死率,这种疾病在人群中的死亡负担相当大。广泛筛查胸主动脉瘤尚未被证明具有成本效益。因此,目前大多数胸主动脉瘤患者是在因其他原因进行的影像学检查中偶然发现的。一旦确诊胸主动脉瘤,对于升主动脉、主动脉弓以及降主动脉或胸腹主动脉的动脉瘤,可安全地进行预防性手术治疗,从而预防与动脉瘤相关的死亡。为便于早期发现胸主动脉瘤,近期研究已确定了几种胸主动脉瘤的“相关因素”,这些因素可能有助于及时做出诊断。这些“相关因素”包括颅内动脉瘤、主动脉弓异常、腹主动脉瘤、单纯肾囊肿、二叶式主动脉瓣、颞动脉炎、动脉瘤疾病家族史阳性以及拇指-手掌征阳性等。尽管对于许多这些“相关因素”,解释其关联的潜在机制仍有待阐明,但临床相关性足够强,表明应对有这些发现的患者进行胸主动脉瘤筛查。本文介绍了基于检测与无症状胸主动脉疾病相关的临床标志物来检测该病的“关联有罪”范式。